On Sunday, 3 January, Covaxin became India's first indigenously produced vaccine against the novel coronavirus to get 'emergency approval in public health interest in clinical trial mode.’
The vaccine is jointly made by Bharat Biotech, Indian Council of Medical Research and National Institute of Virology.